SlideShare a Scribd company logo
CVD Risk
Assessment for 20
Patients and Grant
Proposal
Mitch Hayes
VMS 3
August 28, 2016
Case
 PMH
 HLD
 T2DM
 HTN
 Gout
 SH: single, one child, smokes 1/2 ppd,
drinks occasionally, drives forklift
 FH: father died at 49 of CAD
Case continued
 PE:
 P 85, BP 132/74, RR 18, BMI 29.6
 CV: no rubs, murmurs, gallops
 Resp: CTAB
 Abd: nontender, NABS
 Labs:
 Total chol 194, HDL 52
 Meds:
 multiple
ASCVD Risk Calculation
 2015: age 56
 Total chol 194, HDL 52 (with statin
therapy)
 SBP 122 from annual clinic visit
 +HTN tx, +DM, current smoker (1/2ppd for
>32 years)
 10 year risk for coronary death, nonfatal MI,
and all stroke:
23.8%
Deaths due to CVD have
decreased in recent years
But CVD continues to be #1
cause of death in USA
Many community resources
available for improvement
ASCVD Risk calculation
Aggregate data
0
10
20
30
40
50
60
40 45 50 55 60 65 70 75 80 85
ASCVD10yearrisk
Age
ASCVD 10 year risk by age
13.8%
Grant Proposal: Smoking
Cessation as a Target of Risk
Reduction
 Smoking cessation
 Why?
 Huge impact on CVD risk
 Huge impact on other risks and overall
health
 Rates of smoking have decreased
significantly in recent decades
 Increased awareness of smoking as a
health risk
Planned intervention
 PCPs will screen patients who smoke and
may be interested in quitting
 Pay health coach $5000 to spend 15
minutes with patients who smoke to develop
plans to quit smoking
 Follow up in 1 year to track success rate
Metric to determine
improvement
 Track patient-reported success rate of
smoking cessation at 1 year
 Continue to provide support to patients
 Continue to track smoking use amongst
patients
Time course
 Review annual physical notes for update on
smoking cessation progress at 1, 2, and 5
years
Defense
 Smoking continues to be a risk factor for
many diseases including CVD
 Smoking cessation interventions can make a
huge impact on a patient’s overall health
 Improvement in health outcomes can lead to
huge cost savings
 $5000 pales in comparison to even one
hospitalization due to nonfatal MI or stroke
Thank you

More Related Content

Similar to Mitch hayes ascvd risk assessment powerpoint

UpdatesOnHypertension (1).pdf
UpdatesOnHypertension (1).pdfUpdatesOnHypertension (1).pdf
UpdatesOnHypertension (1).pdf
jiregnaetichadako
 
Nature of Control & Design HT
Nature of Control & Design HTNature of Control & Design HT
Nature of Control & Design HT
Bhaswat Chakraborty
 
STEP.ppt
STEP.pptSTEP.ppt
STEP.ppt
MALATESHUNDI1
 
Life Expectancy Mortality Overview
Life Expectancy Mortality OverviewLife Expectancy Mortality Overview
Life Expectancy Mortality Overview
markflambert
 
NCDs Burden in Bangladesh
NCDs Burden in BangladeshNCDs Burden in Bangladesh
NCDs Burden in Bangladesh
S.M. Jashim Uddin Razib
 
Hypertension conbinsation therapy 2014
Hypertension conbinsation therapy 2014Hypertension conbinsation therapy 2014
Hypertension conbinsation therapy 2014
Muhamed Al Rohani
 
Vince mak - respiratory and mental health
Vince mak - respiratory and mental healthVince mak - respiratory and mental health
Vince mak - respiratory and mental health
NHS Improving Quality
 
Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020
PandurangChavan11
 
The use of mobile solutions in cardiovascular disease trials
The use of mobile solutions in cardiovascular disease trials The use of mobile solutions in cardiovascular disease trials
The use of mobile solutions in cardiovascular disease trials
Vikrant Patnaik
 
Management of hypertension in elderly .pdf
Management of  hypertension in elderly .pdfManagement of  hypertension in elderly .pdf
Management of hypertension in elderly .pdf
PROFESSOR DR. MD. TOUFIQUR RAHMAN
 
Cardiovascular Outcome Trials for New Obesity Drugs
Cardiovascular Outcome Trials for New Obesity DrugsCardiovascular Outcome Trials for New Obesity Drugs
Cardiovascular Outcome Trials for New Obesity Drugs
Ed J. Hendricks, M.D.
 
Cardiovascular Outcome Trials for New Obesity Drugs
Cardiovascular Outcome Trials for New Obesity DrugsCardiovascular Outcome Trials for New Obesity Drugs
Cardiovascular Outcome Trials for New Obesity Drugs
Ed J. Hendricks, M.D.
 
Tobacco use and hiv
Tobacco use and hivTobacco use and hiv
Tobacco use and hiv
anangsowah
 
Htn combination thrapy f
Htn combination thrapy fHtn combination thrapy f
Htn combination thrapy f
Muhamed Al Rohani
 
Body
BodyBody
Gigante PHP Presentation
Gigante PHP PresentationGigante PHP Presentation
Gigante PHP Presentation
cig2du
 
Hipertensão Arterial - Slides da JNC7
Hipertensão Arterial - Slides da JNC7Hipertensão Arterial - Slides da JNC7
Hipertensão Arterial - Slides da JNC7
semiologia
 
Joint National Committee
Joint National CommitteeJoint National Committee
Joint National Committee
Mohammed Al-Issa
 
Is cardiovascular screening the best option for reducing future cardiovascula...
Is cardiovascular screening the best option for reducing future cardiovascula...Is cardiovascular screening the best option for reducing future cardiovascula...
Is cardiovascular screening the best option for reducing future cardiovascula...
UKFacultyPublicHealth
 
Improving heart health in harlem
Improving heart health in harlemImproving heart health in harlem
Improving heart health in harlem
Colin L. Powell Center for Leadership and Service
 

Similar to Mitch hayes ascvd risk assessment powerpoint (20)

UpdatesOnHypertension (1).pdf
UpdatesOnHypertension (1).pdfUpdatesOnHypertension (1).pdf
UpdatesOnHypertension (1).pdf
 
Nature of Control & Design HT
Nature of Control & Design HTNature of Control & Design HT
Nature of Control & Design HT
 
STEP.ppt
STEP.pptSTEP.ppt
STEP.ppt
 
Life Expectancy Mortality Overview
Life Expectancy Mortality OverviewLife Expectancy Mortality Overview
Life Expectancy Mortality Overview
 
NCDs Burden in Bangladesh
NCDs Burden in BangladeshNCDs Burden in Bangladesh
NCDs Burden in Bangladesh
 
Hypertension conbinsation therapy 2014
Hypertension conbinsation therapy 2014Hypertension conbinsation therapy 2014
Hypertension conbinsation therapy 2014
 
Vince mak - respiratory and mental health
Vince mak - respiratory and mental healthVince mak - respiratory and mental health
Vince mak - respiratory and mental health
 
Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020
 
The use of mobile solutions in cardiovascular disease trials
The use of mobile solutions in cardiovascular disease trials The use of mobile solutions in cardiovascular disease trials
The use of mobile solutions in cardiovascular disease trials
 
Management of hypertension in elderly .pdf
Management of  hypertension in elderly .pdfManagement of  hypertension in elderly .pdf
Management of hypertension in elderly .pdf
 
Cardiovascular Outcome Trials for New Obesity Drugs
Cardiovascular Outcome Trials for New Obesity DrugsCardiovascular Outcome Trials for New Obesity Drugs
Cardiovascular Outcome Trials for New Obesity Drugs
 
Cardiovascular Outcome Trials for New Obesity Drugs
Cardiovascular Outcome Trials for New Obesity DrugsCardiovascular Outcome Trials for New Obesity Drugs
Cardiovascular Outcome Trials for New Obesity Drugs
 
Tobacco use and hiv
Tobacco use and hivTobacco use and hiv
Tobacco use and hiv
 
Htn combination thrapy f
Htn combination thrapy fHtn combination thrapy f
Htn combination thrapy f
 
Body
BodyBody
Body
 
Gigante PHP Presentation
Gigante PHP PresentationGigante PHP Presentation
Gigante PHP Presentation
 
Hipertensão Arterial - Slides da JNC7
Hipertensão Arterial - Slides da JNC7Hipertensão Arterial - Slides da JNC7
Hipertensão Arterial - Slides da JNC7
 
Joint National Committee
Joint National CommitteeJoint National Committee
Joint National Committee
 
Is cardiovascular screening the best option for reducing future cardiovascula...
Is cardiovascular screening the best option for reducing future cardiovascula...Is cardiovascular screening the best option for reducing future cardiovascula...
Is cardiovascular screening the best option for reducing future cardiovascula...
 
Improving heart health in harlem
Improving heart health in harlemImproving heart health in harlem
Improving heart health in harlem
 

Recently uploaded

English Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptxEnglish Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptx
MatSouthwell1
 
GIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure andGIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure and
MuzafarBohio
 
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSONNEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
SHAMIN EABENSON
 
National Rural Health Mission(NRHM).pptx
National Rural Health Mission(NRHM).pptxNational Rural Health Mission(NRHM).pptx
National Rural Health Mission(NRHM).pptx
Jyoti Chand
 
Monopoly PCD Pharma Franchise in Tripura
Monopoly PCD Pharma Franchise in TripuraMonopoly PCD Pharma Franchise in Tripura
Monopoly PCD Pharma Franchise in Tripura
SKG Internationals
 
Get Covid Testing at Fit to Fly PCR Test
Get Covid Testing at Fit to Fly PCR TestGet Covid Testing at Fit to Fly PCR Test
Get Covid Testing at Fit to Fly PCR Test
NX Healthcare
 
FACIAL NERVE
FACIAL NERVEFACIAL NERVE
FACIAL NERVE
aditigupta1117
 
ilide.info-assessment-of-renal-and-urinary-tract-function-pr_1aae1860e4cff0a4...
ilide.info-assessment-of-renal-and-urinary-tract-function-pr_1aae1860e4cff0a4...ilide.info-assessment-of-renal-and-urinary-tract-function-pr_1aae1860e4cff0a4...
ilide.info-assessment-of-renal-and-urinary-tract-function-pr_1aae1860e4cff0a4...
HannahDy7
 
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Levi Shapiro
 
CHAPTER 1 SEMESTER V COMMUNICATION TECHNIQUES FOR CHILDREN.pdf
CHAPTER 1 SEMESTER V  COMMUNICATION TECHNIQUES FOR CHILDREN.pdfCHAPTER 1 SEMESTER V  COMMUNICATION TECHNIQUES FOR CHILDREN.pdf
CHAPTER 1 SEMESTER V COMMUNICATION TECHNIQUES FOR CHILDREN.pdf
Sachin Sharma
 
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdfU Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
Jokerwigs arts and craft
 
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Lighthouse Retreat
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
eurohealthleaders
 
Vicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdfVicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdf
Arunima620542
 
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdfVEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
Vedanta A
 
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPTNURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
blessyjannu21
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
Chandrima Spa Ajman
 
Know Latest Hiranandani Hospital Powai News.pdf
Know Latest Hiranandani Hospital Powai News.pdfKnow Latest Hiranandani Hospital Powai News.pdf
Know Latest Hiranandani Hospital Powai News.pdf
Dr. Sujit Chatterjee CEO Hiranandani Hospital
 
Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.
Vishal kr Thakur
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
priyabhojwani1200
 

Recently uploaded (20)

English Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptxEnglish Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptx
 
GIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure andGIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure and
 
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSONNEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
 
National Rural Health Mission(NRHM).pptx
National Rural Health Mission(NRHM).pptxNational Rural Health Mission(NRHM).pptx
National Rural Health Mission(NRHM).pptx
 
Monopoly PCD Pharma Franchise in Tripura
Monopoly PCD Pharma Franchise in TripuraMonopoly PCD Pharma Franchise in Tripura
Monopoly PCD Pharma Franchise in Tripura
 
Get Covid Testing at Fit to Fly PCR Test
Get Covid Testing at Fit to Fly PCR TestGet Covid Testing at Fit to Fly PCR Test
Get Covid Testing at Fit to Fly PCR Test
 
FACIAL NERVE
FACIAL NERVEFACIAL NERVE
FACIAL NERVE
 
ilide.info-assessment-of-renal-and-urinary-tract-function-pr_1aae1860e4cff0a4...
ilide.info-assessment-of-renal-and-urinary-tract-function-pr_1aae1860e4cff0a4...ilide.info-assessment-of-renal-and-urinary-tract-function-pr_1aae1860e4cff0a4...
ilide.info-assessment-of-renal-and-urinary-tract-function-pr_1aae1860e4cff0a4...
 
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
 
CHAPTER 1 SEMESTER V COMMUNICATION TECHNIQUES FOR CHILDREN.pdf
CHAPTER 1 SEMESTER V  COMMUNICATION TECHNIQUES FOR CHILDREN.pdfCHAPTER 1 SEMESTER V  COMMUNICATION TECHNIQUES FOR CHILDREN.pdf
CHAPTER 1 SEMESTER V COMMUNICATION TECHNIQUES FOR CHILDREN.pdf
 
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdfU Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
 
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
 
Vicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdfVicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdf
 
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdfVEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
 
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPTNURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
 
Know Latest Hiranandani Hospital Powai News.pdf
Know Latest Hiranandani Hospital Powai News.pdfKnow Latest Hiranandani Hospital Powai News.pdf
Know Latest Hiranandani Hospital Powai News.pdf
 
Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
 

Mitch hayes ascvd risk assessment powerpoint

  • 1. CVD Risk Assessment for 20 Patients and Grant Proposal Mitch Hayes VMS 3 August 28, 2016
  • 2. Case  PMH  HLD  T2DM  HTN  Gout  SH: single, one child, smokes 1/2 ppd, drinks occasionally, drives forklift  FH: father died at 49 of CAD
  • 3. Case continued  PE:  P 85, BP 132/74, RR 18, BMI 29.6  CV: no rubs, murmurs, gallops  Resp: CTAB  Abd: nontender, NABS  Labs:  Total chol 194, HDL 52  Meds:  multiple
  • 4. ASCVD Risk Calculation  2015: age 56  Total chol 194, HDL 52 (with statin therapy)  SBP 122 from annual clinic visit  +HTN tx, +DM, current smoker (1/2ppd for >32 years)  10 year risk for coronary death, nonfatal MI, and all stroke: 23.8%
  • 5. Deaths due to CVD have decreased in recent years
  • 6. But CVD continues to be #1 cause of death in USA
  • 9. Aggregate data 0 10 20 30 40 50 60 40 45 50 55 60 65 70 75 80 85 ASCVD10yearrisk Age ASCVD 10 year risk by age 13.8%
  • 10. Grant Proposal: Smoking Cessation as a Target of Risk Reduction  Smoking cessation  Why?  Huge impact on CVD risk  Huge impact on other risks and overall health  Rates of smoking have decreased significantly in recent decades  Increased awareness of smoking as a health risk
  • 11. Planned intervention  PCPs will screen patients who smoke and may be interested in quitting  Pay health coach $5000 to spend 15 minutes with patients who smoke to develop plans to quit smoking  Follow up in 1 year to track success rate
  • 12. Metric to determine improvement  Track patient-reported success rate of smoking cessation at 1 year  Continue to provide support to patients  Continue to track smoking use amongst patients
  • 13. Time course  Review annual physical notes for update on smoking cessation progress at 1, 2, and 5 years
  • 14. Defense  Smoking continues to be a risk factor for many diseases including CVD  Smoking cessation interventions can make a huge impact on a patient’s overall health  Improvement in health outcomes can lead to huge cost savings  $5000 pales in comparison to even one hospitalization due to nonfatal MI or stroke